Form 4: Corcept Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Sean Maduck, See Remarks of Corcept Therapeutics Inc, sold 3,664 shares of common stock on August 14, 2026 for $114.49 per share.
Summary
- Option exercise/conversion: acquired 3,664 Common Stock at $8.27 ($30,301) on August 14, 2026; holds 13,419 after (Direct).
- Open-market sale: disposed of 3,664 Common Stock at $114.49 ($419,491) on August 14, 2026; holds 9,755 after (Direct).
- Option exercise/conversion: disposed of 3,664 Stock option (right to buy) on August 14, 2026; holds 91,986 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $419,491 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Sean Maduck — Officer (See Remarks)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Option exercise/conversion | Common Stock | 3,664 | $8 | $30.3K | 13,419 |
| 2026-08-14 | Open-market sale | Common Stock | 3,664 | $114 | $419.5K | 9,755 |
| 2026-08-14 | Option exercise/conversion | Stock option (right to buy) | 3,664 | — | — | 91,986 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Option exercise/conversion (3,664 shares) |
| 2026-08-14 | Open-market sale (3,664 shares) |
| 2026-08-14 | Option exercise/conversion (3,664 shares) |
Keywords
insider transaction, Form 4, CORT, CORCEPT THERAPEUTICS INC, bearish, Sean Maduck
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.